Radiation 'Grid' tried to reboot failed cancer drug
NCT ID NCT05443971
Summary
This small, early-stage study tested if a special, targeted radiation technique called 'grid therapy' could help the immunotherapy drug durvalumab work again for patients with non-small cell lung cancer. The patients had already tried durvalumab, but their cancer started growing again. The main goal was to check the safety of combining these two treatments. The study was terminated early after enrolling only four patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LUNG NON-SMALL CELL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Mayo Clinic in Rochester
Rochester, Minnesota, 55905, United States
Conditions
Explore the condition pages connected to this study.